Literature DB >> 28819850

RareCyte® CTC Analysis Step 2: Detection of Circulating Tumor Cells by CyteFinder® Automated Scanning and Semiautomated Image Analysis.

Jeffrey L Werbin1, Joshua J Nordberg1, Jay Tzucker1, Paulina Varshavskaya1, Jackie L Stilwell1, Eric P Kaldjian2.   

Abstract

The RareCyte CyteFinder instrument is an automated scanner that allows rapid identification of circulating tumor cells (CTCs) on microscope slides prepared by the AccuCyte process (see Chapter 13 ) and stained by immunofluorescence. Here, we present the workflow for CyteFinder scanning, analysis, and CyteMapper scan review which includes CTC confirmation and report generation.

Entities:  

Keywords:  Circulating tumor cells; Fluorescence scanning; Image analysis; Scoring algorithm

Mesh:

Substances:

Year:  2017        PMID: 28819850     DOI: 10.1007/978-1-4939-7144-2_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development.

Authors:  Abhijit Pal; Rajiv Shinde; Manuel Selvi Miralles; Paul Workman; Johann de Bono
Journal:  Nat Rev Clin Oncol       Date:  2021-03-24       Impact factor: 66.675

2.  The RareCyte® platform for next-generation analysis of circulating tumor cells.

Authors:  Eric P Kaldjian; Arturo B Ramirez; Yao Sun; Daniel E Campton; Jeffrey L Werbin; Paulina Varshavskaya; Steven Quarre; Tad George; Anup Madan; C Anthony Blau; Ronald Seubert
Journal:  Cytometry A       Date:  2018-10-02       Impact factor: 4.355

Review 3.  Carbonic anhydrase IX as a novel candidate in liquid biopsy.

Authors:  Ozen Ozensoy Guler; Claudiu T Supuran; Clemente Capasso
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.